Preference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina.
Sergio SciannameoVirginia ZalazarLuciana SpadacciniMariana DuartePedro CahnInes AristeguiOmar SuedPublished in: Therapeutic advances in infectious disease (2024)
The strong preference for LAI-ART suggests the potential for improved adherence and well-being among people with HIV. Additionally, the preference for LAI-PrEP among those without HIV emphasizes the importance of considering this option for HIV prevention strategies. This study highlights the need to offer diverse methods for ART and prevention to accommodate different preferences and improve health care outcomes in Latin America.
Keyphrases